BioStem Technologies, Inc., a developer of placental-derived products for wound care, recently announced that patient ...

Lavior Pharma Inc., a woman-owned pharmaceutical company developing innovative therapies for chronic and acute conditions, today announced the appointment of Dr. Imaze Marian Davis, DPM, MBA, DABPM, ...

Next‑Gen Amnio-Chorionic Membrane for Enhanced Wound Care is Latest Offering in a Slew of New Products Focused on Increasing Patient Care ...

Diabetes is one of the most common health conditions in the world, which can cause serious complications and manifest as skin ...

As we enjoy the long, hot summer, we think of long strolls on the beach and the feel of sand through our toes. We never think of the dangers that ...

Factors such as a rise in chronic conditions and advanced medical technologies are driving demand. Innovations in compression technology and wound ca ...

The global anti-biofilm wound dressing market is estimated to be valued at USD 954.6 million in 2025 and is projected to ...

The global chronic wound care market is estimated to be valued at USD 18.6 billion in 2025 and is projected to reach USD 26.7 billion by 2035, registering a compound annual growth rate (CAGR) of 3.7% ...